Lung volume reduction surgery shown to prolong and improve life for some emphysema patients

...ung volume reduction surgery (LVRS) can have a significantly beneficial effect in patients with severe emphysema, according to the first ever study to randomize emphysema patients to receive either LVRS or non-surgical medical care. "We found lung reduction surgery is good treatment alternative for selected...

Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma, Mayo Clinic Researchers Say

...-month progression-free survival (PFS) of 67 to 79 percent. The NCCTG multi-institutional research network is planning a clinical trial that will randomize patients with high-risk diffuse large B-cell lymphoma to either this regimen, known as ER-CHOP, or to R-CHOP, the standard treatment. R-CHOP includes ...

Two targeted therapies likely better than one in patients with aggressive lymphoma

...12-month progression-free survival (PFS) of 67 to 79 percent. The NCCTG multi-institutional research network is planning a clinical trial that will randomize patients with high-risk diffuse large B-cell lymphoma to either this regimen, known as ER-CHOP, or to R-CHOP, the standard treatment. R-CHOP includes...

Mexican health care program successful at reducing crippling health care costs

...s from politics to public health are now opting to randomize clusters of people, rather than individuals, accor...fficacy of various get-out-the-vote strategies may randomize households, rather than individual voters. Public health investigators may randomize hospitals rather than patients. But, for statis...

GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer

... fludarabine and cyclophosphamide (FC) for patients with CLL when initial treatment no longer works (second-line treatment). The open-label study will randomize 352 patients to evaluate progression-free survival (PFS) of ofatumumab in combination with FC therapy versus FC therapy alone for the treatment of rel...

Tufts receives NIH grant to study obesity prevention in new immigrants

...th (NIH) to design an obesity prevention program for new immigrants. Led by Principal Investigator Christina D. Economos, PhD, the clinical trial will randomize more than 400 mothers and their elementary school age children living in Somerville, Mass., and follow them for two years. "A previous Tufts resear...

No Difference Found in Treatments for Acute Kidney Failure

...unt for these comorbidities, you can't account for what a treatment is actually contributing," he said. "The more complex it gets, the harder it is to randomize patients into a study. Depending on what the patients suffer from, the outcomes are quite variable." The incidence of acute kidney failure appears ...

Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study

...nificant antitumor activity as reported in recent pivotal clinical trials. To further characterize the activity of sorafenib, this clinical trial will randomize patients with metastatic breast cancer to receive weekly paclitaxel or the combination of paclitaxel and sorafenib. This trial will determine if an or...

Surgery- Very Effective for Common Back Pain

...fully the surgical and nonsurgical options available to our patients so that they can make an informed choice. The study initially intended to randomize patients into either a surgical or nonsurgical group and then observe and compare the results of the two groups. Unfortunately, a comparison of the tw...

Randomize in Medical Technology

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

...or surgically clipped patients (at present, there is no opportunity to compare to patients who are surgically clipped as it is considered unethical to randomize patients to coiling versus clipping following sound evidence that demonstrates that if an aneurysm is suitable for either treatment, that coiling is a...

Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation

... significantly higher in the twice-daily DU-176b treatment groups (30 mg or 60 mg), compared to the warfarin group. The Phase III study will therefore randomize approximately 16,500 patients to one of three treatment groups: 30 mg DU-176b once daily, 60 mg DU-176b once daily, or warfarin. Those randomized to ...

Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America

...m," stated Dr. Carl Spana, Palatin's President and Chief Executive Officer. "A clinical study is targeted to start later this calendar year which will randomize chronic heart failure patients to receive daily subcutaneous injections of PL-3994 in addition to their existing drug regimens. While existing medicat...

Concentric Medical to Sponsor Randomized Trial

...rial of Endovascular TReatment of acute Ischemic strokE Versus mEdical management). The trial, which will enroll in centers throughout the world, will randomize patients between treatment with the Merci Retriever(R) and non-interventional, best medical therapy. Enrollment is expected to begin in 2009. "We be...

Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)

...icans suffer from the disease. Results from the trial are expected to be announced in early 2010. This double-blinded, placebo-controlled trial will randomize up to 48 patients at five research sites in the U.S. Primary clinical endpoints of the study are peak walking time and claudication onset time, as dem...

Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule

...ch is being conducted in treatment-naive patients with genotype 1 chronic hepatitis C. ACHIEVE 2/3 was initiated in February 2007, and will enroll and randomize a minimum of 918 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C. Enrollment in ACHIEVE 2/3 is also progressing well, and will be ...

Randomize in Medical Products

Velo 4000M LCD Chart Display

Features:... 3 year warranty Contrast sensitivity testing Greater number of charts and tests including green/red Can randomize chart letters Simple to control with a remote or electronic phoropter High tech image for the practice...
Company:Burton Ophthalmic

Randomize in Biological Technology

Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain

...nkle sprain and wrist injury studies will each enroll 208 subjects, and the soft tissue injury study will enroll 400 subjects. All three studies will randomize subjects to receive Cerimon's topical diclofenac sodium patch or placebo at a ratio of 1:1. "Results from our Phase II acute ankle sprain study ...